Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LIFITEGRAST vs LINCOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LIFITEGRAST vs LINCOMYCIN: Safety Overview

Metric LIFITEGRAST LINCOMYCIN
Total FAERS Reports 13,412 210
Deaths Reported 234 21
Death Rate 1.7% 10.0%
Hospitalizations 282 37
Average Patient Age 64.8 yrs 46.3 yrs
% Female Patients 82.8% 69.3%
FDA Approval Date Aug 4, 2023 Approved Prior to Jan 1, 1982
Manufacturer Bausch & Lomb Incorporated Pharmacia & Upjohn Company LLC
Route OPHTHALMIC INTRAMUSCULAR
Marketing Status Prescription Discontinued